Results 101 to 110 of about 5,639 (136)

GDF15 is a putative biomarker for distinguishing pulmonary veno-occlusive disease and pulmonary arterial hypertension. [PDF]

J Clin Invest
Prabhakar A, De Bie EM, DesJardin JT, Ghatpande P, Gräf S, Howard LS, Wort SJ, Church C, Kiely DG, UK Pulmonary Arterial Hypertension Cohort Study Consortium, Sumpena E, Aung T, Carter S, Kukreja J, Hays S, Greenland JR, Singer JP, Wax M, Wolters PJ, Simon MA, Toshner M, Lagna G, Hata A.   +22 more
europepmc   +1 more source

Good response to pulmonary arterial hypertension-targeted therapy in 2 pulmonary veno-occlusive disease patients: A case report. [PDF]

Medicine (Baltimore), 2021
Zhang L, Wang Y, Zhang R.
europepmc   +1 more source

Pulmonary veno-occlusive disease masquerading as chronic thrombo embolic pulmonary hypertension

, 2017
Pulmonary veno-occlusive disease (PVOD) is a rare cause of Group 1 Pulmonary Hypertension (PH) characterized by preferential remodeling of the pulmonary venules.
Hegab, Sara, Razvi, S. A, Abu Sayf, Alaa, Razvi, S A, Al-Darzi, Waleed, Awdish, Rana   +5 more
core  

Pulmonary Veno-Occlusive Disease: A Comprehensive Review of Diagnostic Challenges, Therapeutic Limitations, and Evolving Management. [PDF]

Adv Respir Med
Foster B, Khan S, Suarez Gonzalez A, Gillenwater S.   +3 more
europepmc   +1 more source

Patient-specific and gene-corrected induced pluripotent stem cell-derived endothelial cells elucidate single-cell phenotype of pulmonary veno-occlusive disease. [PDF]

Stem Cell Reports, 2022
Ma B, Li T, Li W, Yang H, Zeng Q, Pan Z, Wang K, Chen Q, Xiong C, Zhou Z.   +9 more
europepmc   +1 more source

Essential role of protein kinase R in the pathogenesis of pulmonary veno-occlusive disease. [PDF]

JCI Insight
Prabhakar A, Kumar R, Wadhwa M, Barpanda A, Lyons J, Gowda A, Gupta S, Arvind A, Ghatpande P, Wiita AP, Graham BB, Lagna G, Hata A.   +12 more
europepmc   +1 more source

Differential Expression Profile of microRNAs and Tight Junction in the Lung Tissues of Rat With Mitomycin-C-Induced Pulmonary Veno-Occlusive Disease. [PDF]

Front Cardiovasc Med, 2022
Song Q, Chen P, Wu SJ, Chen Y, Zhang Y.
europepmc   +1 more source

Pulmonary veno-occlusive disease: a clinical review. [PDF]

Breathe (Sheff)
Deshwal H, Sarkar S, Basu A, Jalil BA.
europepmc   +1 more source

Intravenous mesenchymal stem cell transplantation mitigates pulmonary vascular remodeling but poses dose related risks in a pulmonary veno-occlusive disease model. [PDF]

Stem Cell Res Ther
Katagiri J, Homma J, Takagi R, Sekine H, Shinkawa T, Niinami H, Shimizu T.   +6 more
europepmc   +1 more source

Patient-specific and gene-corrected induced pluripotent stem cell-derived endothelial cells elucidate single-cell phenotype of pulmonary veno-occlusive disease. [PDF]

Stem Cell Reports
Ma B, Li T, Li W, Yang H, Zeng Q, Pan Z, Wang K, Chen Q, Xiong C, Zhou Z.   +9 more
europepmc   +1 more source